Is Choksi Laboratories Ltd debt-free?

No, Choksi Laboratories Ltd is not debt-free with a debt-to-equity ratio of 1.20.

Home

Choksi Laboratories Ltd

Choksi Laboratories Ltd Financials

Choksi Laboratories Ltd Financial Statement

Choksi Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2025	Mar 2025	Dec 2024
Revenue	11.25	11.44	10.39
Operating Expense	8.34	7.90	7.84
Net Profit	0.39	0.92	0.11
Net Profit Margin	3.47	8.04	1.06
Earning Per Share	0.55	1.32	0.15
EBIDTA	2.79	3.79	2.62
Effective Tax Rate	4.14	16.62	5.49

Particulars	Jun 2025
Revenue	11.25
Operating Expense	8.34
Net Profit	0.39
Net Profit Margin	3.47
Earning Per Share	0.55
EBIDTA	2.79
Effective Tax Rate	4.14

Choksi Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	41.78	36.70	34.44
Operating Expenses Annual	30.55	26.48	24.20
Operating Profit Annual	11.30	10.38	12.71
Interest Annual	2.65	3.01	3.49
Depreciation	6.50	5.71	5.50
Net Profit Annual	1.52	1.11	3.21
Tax Annual	0.63	0.55	0.51

Particulars	Mar 2025
Total Revenue Annual	41.78
Operating Expenses Annual	30.55
Operating Profit Annual	11.30
Interest Annual	2.65
Depreciation	6.50
Net Profit Annual	1.52
Tax Annual	0.63

Choksi Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	0.66	0.34	0.41
Cash Flow from Operations	11.78	11.55	8.25
Cash Flow from Investing	-7.61	-6.65	-0.71
Cash Flow from Financing	-4.22	-4.58	-7.61
Cash Flow at the End	0.61	0.66	0.34

Particulars	Mar 2025
Cash Flow at the Beginning	0.66
Cash Flow from Operations	11.78
Cash Flow from Investing	-7.61
Cash Flow from Financing	-4.22
Cash Flow at the End	0.61

Choksi Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	27.21	28.45	30.43
PBIT Margin (%)	11.66	12.89	14.46
PBT Margin (%)	7.38	8.69	10.37
Net PROFIT Margin (%)	3.64	3.02	9.32
Return On Networth / Equity (%)	6.63	5.12	8.41
Return On Networth /Employed (%)	8.89	8.58	8.92
Return On Assets (%)	2.76	2.03	5.78
Total Debt / Equity (X)	1.31	1.46	1.79
Asset Turnover Ratio (%)	0.76	0.67	0.62

Particulars	Mar 2025
PBDIT Margin (%)	27.21
PBIT Margin (%)	11.66
PBT Margin (%)	7.38
Net PROFIT Margin (%)	3.64
Return On Networth / Equity (%)	6.63
Return On Networth /Employed (%)	8.89
Return On Assets (%)	2.76
Total Debt / Equity (X)	1.31
Asset Turnover Ratio (%)	0.76

Choksi Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	47.61	43.75	45.12
Total Current Assets Annual	16.32	14.57	13.95
Non Current Assets Annual	49.01	47.38	46.42
Total Shareholders Funds Annual	23.60	22.21	21.11
Total Assets Annual	65.33	61.95	60.36

Particulars	Mar 2025
Fixed Assets Annual	47.61
Total Current Assets Annual	16.32
Non Current Assets Annual	49.01
Total Shareholders Funds Annual	23.60
Total Assets Annual	65.33

Choksi Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Choksi Laboratories Ltd Financials

As of Sep 17, 2025, Choksi Laboratories Ltd has a market capitalization of 83.69 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Choksi Laboratories Ltd is not with a debt-to-equity ratio of 1.20.

In FY 2024 , Choksi Laboratories Ltd recorded a total revenue of approximately 41.78 Cr marking a significant milestone in the company's financial performance.

Choksi Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.6% and 0.1% annually, respectively..

Choksi Laboratories Ltd's current PE ratio is 55.06.

Choksi Laboratories Ltd's ROCE averaged 9.1% from the FY ending March 2023 to 2025, with a median of 9.1%. It peaked at 9.3% in March 2023, reflecting strong capital efficiency over the period..

Choksi Laboratories Ltd's latest EBIT is Rs. 4.80 Cr, surpassing the average EBIT of Rs. 5.56 Cr over the 5 years..